| dbo:abstract
|
- Nimmi Ramanujam is the Robert W. Carr Professor of Biomedical Engineering, and a faculty member in the Global Health Institute and the Department of Pharmacology & Cell Biology at Duke University. She is the director of the Center of Global Women's Health Technologies (GWHT) and founder of Zenalux Biomedical Inc. and Calla Health. Ramanujam has spent the last two decades developing precision diagnostics and more recently precision therapeutics for breast and cervical cancer, with a focus on addressing global health disparities. She has more than 20 patents and over 150 publications for screening, diagnostic, and surgical applications, and has raised over $30M of funding to pursue these innovations through a variety of funding mechanisms, including NIH R01s and R21s, NIH Bioengineering Partnerships, NCI Academic Industry Partnerships, NIH Small Business grants and USAID funding. As the founding director of the Center for Global Women's Health Technologies at Duke University, she has developed a consortium of over 50+ partners including international academic institutions and hospitals, non-governmental organizations, ministries of health, and commercial partners; this consortium is working to ensure that the technologies developed at the center are adopted by cancer control programs in geographically and economically diverse healthcare settings. (en)
|
| dbo:academicDiscipline
| |
| dbo:award
| |
| dbo:institution
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 15612 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:awards
|
- Fellow of the American Institute for Medical and Biological Engineering, Optical Society of America SPIE, National Academy of Inventors, and Fulbright Program: TR100 Award , Global Indus Technovator Award , Era of Hope Scholar Award , Stasnell Research Award , Emerging Leader Award , WIMIN Leadership Award , Social Impact Abie Award, 2020 SPIE Biophotonics Technology Innovator Award (en)
|
| dbp:education
| |
| dbp:fields
|
- Biomedical engineering (en)
- Global health (en)
- Biophotonics (en)
- Women's cancers (en)
|
| dbp:knownFor
|
- Cancer screening technology (en)
- Design-based STEM program, Ignite (en)
- Inventing the pocket colposcope and callascope (en)
- WISH Revolution program (en)
|
| dbp:name
| |
| dbp:website
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:workplaces
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Nimmi Ramanujam is the Robert W. Carr Professor of Biomedical Engineering, and a faculty member in the Global Health Institute and the Department of Pharmacology & Cell Biology at Duke University. She is the director of the Center of Global Women's Health Technologies (GWHT) and founder of Zenalux Biomedical Inc. and Calla Health. Ramanujam has spent the last two decades developing precision diagnostics and more recently precision therapeutics for breast and cervical cancer, with a focus on addressing global health disparities. She has more than 20 patents and over 150 publications for screening, diagnostic, and surgical applications, and has raised over $30M of funding to pursue these innovations through a variety of funding mechanisms, including NIH R01s and R21s, NIH Bioengineering Part (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
